Findings

What do systematic reviews say?

150 questions · 164 findings · 14 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 32 · 19.5%GRADE not reported 35 · 21.3%Very low 62 · 37.8%Low 21 · 12.8%Moderate 14 · 8.5%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Direct match · question page
- Tetracycline vs placebo · Lesion count
  Interventions for rosacea 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 39 participants
  Moderate
Direct match · question page
- Tetracycline vs placebo · Physician‐assessed improvement in rosacea severity
  Interventions for rosacea 2015 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 107 participants
  Moderate
Direct match · question page
- Tetracycline vs placebo · Participant‐assessed improvement in rosacea severity
  Interventions for rosacea 2015 · Cochrane Headline outcomes only
  RR 1.48 [0.85, 2.57]
  1 study · 39 participants
  Moderate
Direct match · question page
- Tetracycline vs placebo · Assessment of erythema or telangiectasia
  Interventions for rosacea 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 39 participants
  Moderate
Direct match · question page
- Oral tetracycline vs topical clindamycin · Nodules score Nodule count
  Interventions for hidradenitis suppurativa 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 34 participants
  Low

Tetracycline vs penicillin G

Leukocytosis resolution time (days) · patients with septic abortion

1 finding from 1 review

Antibiotics for treating septic abortion 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 100 participants
Low

Tetracycline vs penicillin G

Fever clearance time · patients with septic abortion

1 finding from 1 review

Antibiotics for treating septic abortion 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 100 participants
Low

Tetracycline vs placebo

HRQOL ‐ not measured · Participants with rosacea

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tetracycline vs placebo

Participant‐assessed improvement in rosacea severity · Participants with rosacea

Tetracycline showed no clear difference in participant‐assessed improvement in rosacea severity compared with placebo (moderate certainty).

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
RR 1.48 [0.85, 2.57]
1 study · 39 participants
Moderate

Tetracycline vs placebo

Proportion of participants with adverse event · Participants with rosacea

Tetracycline showed no clear difference in proportion of participants with adverse event compared with placebo (moderate certainty).

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
RR 0.95 [0.06, 14.13]
1 study · 39 participants
Moderate

Tetracycline vs placebo

Physician‐assessed improvement in rosacea severity · Participants with rosacea

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 107 participants
Moderate

Tetracycline vs placebo

Assessment of erythema or telangiectasia · Participants with rosacea

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

Tetracycline vs placebo

Lesion count · Participants with rosacea

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Moderate

Tetracycline vs placebo

Time needed until improvement of the skin lesions · Participants with rosacea

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tetracycline vs placebo

Duration of remission ‐ not measured · Participants with rosacea

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tetracycline vs doxycycline

Duration of diarrhoea · Adults and children with cholera diarrhoea

1 finding from 1 review

Antimicrobial drugs for treating cholera 2014 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 230 participants
Moderate

Tetracycline vs doxycycline

Stool volume · Adults and children with cholera diarrhoea

1 finding from 1 review

Antimicrobial drugs for treating cholera 2014 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 336 participants
Moderate

Tetracycline vs doxycycline

Bacteriological failure · Adults and children with cholera diarrhoea

Tetracycline probably leads to lower bacteriological failure compared with doxycycline (moderate certainty).

1 finding from 1 review

Antimicrobial drugs for treating cholera 2014 · Cochrane Headline outcomes only
RR 0.2 [0.06, 0.68]
2 studies · 198 participants
Moderate

Tetracycline vs quinolones

Duration of diarrhoea · Adults and children with cholera diarrhoea

1 finding from 1 review

Antimicrobial drugs for treating cholera 2014 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 259 participants
Moderate

Tetracycline vs quinolones

Stool volume · Adults and children with cholera diarrhoea

1 finding from 1 review

Antimicrobial drugs for treating cholera 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 236 participants
Low

Tetracycline vs quinolones

Bacteriological failure · Adults and children with cholera diarrhoea

Tetracycline showed no clear difference in bacteriological failure compared with quinolones (low certainty).

1 finding from 1 review

Antimicrobial drugs for treating cholera 2014 · Cochrane Headline outcomes only
RR 0.99 [0.14, 6.82]
2 studies · 234 participants
Low

Oral tetracycline vs topical clindamycin

Participant global assessment VAS Visual analogue scale (VAS) (0 to 100 mm) · participants with hidradenitis suppurativa

1 finding from 1 review

Interventions for hidradenitis suppurativa 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Low

Oral tetracycline vs topical clindamycin

Pain VAS VAS (0 to 100 mm) · participants with hidradenitis suppurativa

1 finding from 1 review

Interventions for hidradenitis suppurativa 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Low

Oral tetracycline vs topical clindamycin

Nodules score Nodule count · participants with hidradenitis suppurativa

1 finding from 1 review

Interventions for hidradenitis suppurativa 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Low

Oral tetracycline vs topical clindamycin

Abscesses score Abscess count · participants with hidradenitis suppurativa

1 finding from 1 review

Interventions for hidradenitis suppurativa 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Low